Keyword: University of Illinois
Antibiotics dubbed odilorhabdins (ODLs), inspired by soil-dwelling nematodes, hold promise for treating antibiotic-resistant infections.
The $400 million deal gives Novo worldwide rights to an epigenetic treatment of the disease that is closing in on the start of a phase 2 trial.
York University scientists have found that beta blockers could potentially reverse heart failure.
Scientists at the University of Illinois at Chicago are testing a way to repair damaged hearts by transforming skin cells into blood vessels.
A team from the University of Illinois at Chicago has identified a monobody that can block the oncogene’s activity.